1h Free Analyst Time
The Angioscope Device Market size was estimated at USD 251.58 million in 2023, USD 266.77 million in 2024, and is expected to grow at a CAGR of 6.50% to reach USD 391.20 million by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
The angioscope device market includes an arena of medical devices designed for angioscopy, a procedure that allows healthcare professionals to visualize the interior of blood vessels and organs through a small, flexible tube equipped with a light source and camera known as an angioscope. An increase in conditions such as peripheral artery disease and coronary artery disease fuels the demand for diagnostic and therapeutic procedures involving angioscopy. Innovations in angioscope devices, including enhanced imaging capabilities and user-friendly interfaces, have improved their functionality and effectiveness, attracting more healthcare providers.
Rising preference for minimally invasive surgeries among patients and doctors alike for their benefits over traditional open surgeries supports market expansion. However, stringent regulatory requirements for approval of medical devices can delay market entry for new innovations, limiting the market scope. Ensuring the quality and reliability of intricate angioscope systems demands significant expertise and training, posing challenges for healthcare providers. Moreover, coupling angioscope devices with digital tools such as AI for better imaging analysis and patient monitoring may offer new avenues for growth in the market. Ongoing research into compact, wearable angioscope technology could revolutionize outpatient care and remote monitoring, generating opportunities for market expansion in upcoming years.
Regional Insights
In the Americas, particularly in the United States and Canada, there is a high demand for advanced medical technologies due to an aging population and a significant prevalence of cardiovascular diseases. High healthcare expenditure and favorable reimbursement policies further support adopting these technologies in the Americas region. European Union countries strongly prefer high-standard medical treatments supported by extensive public healthcare systems and health insurance coverage. Europe’s stringent regulatory environment ensures that only the most reliable and effective devices are available in the market, with Germany, France, and the UK leading in medical device usage.The Middle East and Africa region presents a mixed scenario where the Gulf Cooperation Council (GCC) countries such as Saudi Arabia and the UAE show increasing investment in health technology, including angioscope devices. Asia Pacific is a rapidly growing region in the market for angioscope devices, and factors such as increasing healthcare infrastructure, rising medical tourism, and growing health awareness are contributing to the market growth in the region. Japan stands out as a significant market with advanced healthcare technologies and substantial investment in medical research. China and India are emerging markets with increasing adoption rates due to improving healthcare policies and the rise of middle-class populations demanding better medical care.
Market Trends by Segment
- Usability: Increasing preference for reusable angioscopes due to convenience and cost considerations
- End User: Diverse scope of applications in diagnostic centers for efficient patient evaluation
Industry Insights
- Market Dynamics
- Market Disruption Analysis
- Porter’s Five Forces Analysis
- Value Chain & Critical Path Analysis
- Pricing Analysis
- Technology Analysis
- Patent Analysis
- Trade Analysis
- Regulatory Framework Analysis
- FPNV Positioning Matrix
- Market Share Analysis
- Strategy Analysis and Recommendations
Recent Developments
Abbott's Introduction of AI-Enhanced Vascular Imaging in India, Revolutionizing Cardiac Care
Abbott Laboratories has introduced a cutting-edge vascular imaging platform in India, which is enhanced by Ultreon 1.0 Software. The advanced system integrates optical coherence tomography (OCT) with artificial intelligence (AI) to provide doctors with a detailed view of blood flow and vessel blockages, enabling precise measurements of vessel diameters. The newly launched technology substantially improves the accuracy of stent deployment during coronary procedures by offering real-time, high-definition imagery from within the blood vessels.Canon Medical Launches Alphenix Evolve Edition Angiography System in European Market
Canon Medical Systems Corporation has launched the Alphenix / Evolve Edition angiography system, designed to support percutaneous coronary intervention (PCI) and structural heart disease procedures by utilizing deep learning technology for enhanced imaging and reduced operational times and radiation doses. The system is a part of Canon Medical’s αEvolve portfolio, which integrates AI-driven technologies to aid real-time diagnostic and therapeutic decision-making processes seamlessly within existing workflows.Abbott Acquires Cardiovascular Systems, Inc. to Enhance Vascular Treatment Technologies
Abbott Laboratories has entered into a definitive agreement to acquire Cardiovascular Systems, Inc. (CSI), a pioneer in the development of atherectomy systems for the treatment of arterial diseases, for approximately USD 890 million. The acquisition is set to enrich Abbott’s portfolio with cutting-edge vascular technologies and an experienced team, reinforcing its position in the vascular intervention market.Key Company Profiles
The report delves into recent significant developments in the Angioscope Device Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Boston Scientific Corporation, Canon Medical Systems, Cardinal Health, Cook Medical, Fujifilm Holdings Corporation, GE Healthcare, Hitachi Medical Corporation, Johnson & Johnson Services, Inc., Karl Storz, LivaNova PLC, Medtronic PLC, Olympus Corporation, Philips Healthcare, Shimadzu Corporation, Siemens Healthineers, Smith & Nephew PLC, Stryker Corporation, Terumo Corporation, Vena Medica, and Zimmer Biomet.This research report offers invaluable insights into various crucial aspects of the Angioscope Device Market:
- Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
- Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
- Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
- Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
- Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.
Additionally, the report addresses key questions to assist stakeholders in making informed decisions:
- What is the current market size and projected growth?
- Which products, segments, applications, and regions offer promising investment opportunities?
- What are the prevailing technology trends and regulatory frameworks?
- What is the market share and positioning of the leading vendors?
- What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?
Table of Contents
1. Preface
2. Research Methodology
5. Market Insights
6. Angioscope Device Market, by Usability
7. Angioscope Device Market, by End User
8. Americas Angioscope Device Market
9. Asia-Pacific Angioscope Device Market
10. Europe, Middle East & Africa Angioscope Device Market
11. Competitive Landscape
12. Competitive Portfolio
List of Figures
List of Tables
Companies Mentioned
- Abbott Laboratories
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Canon Medical Systems
- Cardinal Health
- Cook Medical
- Fujifilm Holdings Corporation
- GE Healthcare
- Hitachi Medical Corporation
- Johnson & Johnson Services, Inc.
- Karl Storz
- LivaNova PLC
- Medtronic PLC
- Olympus Corporation
- Philips Healthcare
- Shimadzu Corporation
- Siemens Healthineers
- Smith & Nephew PLC
- Stryker Corporation
- Terumo Corporation
- Vena Medica
- Zimmer Biomet
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 197 |
| Published | May 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 266.77 Million |
| Forecasted Market Value ( USD | $ 391.2 Million |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
